Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?

Executive Summary

Bolus of applications could be filed once government reopens, but employee morale and recruitment efforts could suffer drop-off.

You may also be interested in...



US House Preview: Health Panels To Push Device Tax Repeal, Shutdown Contingency Bills In 2019

US House lawmakers might pursue legislation in 2019 to repeal the device tax, ensure that FDA can continue working on medtech product reviews during US government shutdowns, and to stabilize the Affordable Care Act to lower health-care costs for patients.

US FDA Inspection Goals Reduced After Shutdown; Review Dates Look Safe

Commissioner Scott Gottlieb tells Congress FDA won’t meet all its planned inspection goals after a month-long partial government shutdown, but he does not expect a noticeable impact on product reviews. Longer-term impacts will depend on morale: hiring and retention are focal points.

Bumps In The Road As US FDA Tries To Catch Up From Shutdown

The recently ended record-setting US government shutdown is not anticipated to have a long-term impact on US FDA device review times. But agency reviewers will face more 510(k) review deadline pressures than usual and may have limited availability for pre-submission meetings in the short term, one expert suggests.

Related Content

Topics

UsernamePublicRestriction

Register

MT124435

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel